Premium
Amelioration of pneumonia with Streptococcus pneumoniae infection by inoculation with a vaccine against highly pathogenic avian influenza virus in a non‐human primate mixed infection model
Author(s) -
Miyake Taichiro,
Soda Kosuke,
Itoh Yasushi,
Sakoda Yoshihiro,
Ishigaki Hirohito,
Nagata Tomoya,
Ishida Hideaki,
Nakayama Misako,
Ozaki Hiroichi,
Tsuchiya Hideaki,
Torii Ryuzo,
Kida Hiroshi,
Ogasawara Kazumasa
Publication year - 2010
Publication title -
journal of medical primatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.31
H-Index - 42
eISSN - 1600-0684
pISSN - 0047-2565
DOI - 10.1111/j.1600-0684.2009.00395.x
Subject(s) - streptococcus pneumoniae , virology , pneumonia , microbiology and biotechnology , virus , highly pathogenic , inoculation , influenza a virus , biology , influenza a virus subtype h5n1 , medicine , immunology , antibiotics
Background Highly pathogenic avian influenza virus (HPAIV) infection has a high mortality rate in humans. Secondary bacterial pneumonia with HPAIV infection has not been reported in human patients, whereas seasonal influenza viruses sometimes enhance bacterial pneumonia, resulting in substantial morbidity and mortality. Therefore, if HPAIV infection were accompanied by bacterial infection, an increase in mortality would be expected. We examined whether a vaccine against HPAIV prevents severe morbidity caused by mixed infection with HPAIV and bacteria. Methods H7N7 subtype of HPAIV and Streptococcus pneumoniae were inoculated into cynomolgus macaques with or without vaccination of inactivated whole virus particles . Results Vaccination against H7N7 HPAIV decreased morbidity caused by HPAIV and pneumonia caused by S. pneumoniae . Bacterial replication in lungs was decreased by vaccination against HPAIV, although the reduction in bacterial colonies was not significant. Conclusions Vaccination against HPAIV reduces pneumonia caused by bacterial superinfection and may improve prognosis of HPAIV‐infected patients.